A Study of Atezolizumab Plus Carboplatin and Etoposide With or Without Tiragolumab in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT04256421 · COMPLETED
Trial details
- NCT number
- NCT04256421
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2022-09-06
- Enrollment
- 490
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.